Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by SASAGU KUROZUMI
Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Related publications
Brain Metastases in Patients With Metastatic Breast Cancer : Prognosis According to Subtype
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Eribulin Mesylate in the Treatment of Metastatic Breast Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Analysis of Eribulin Mesylate Dosing Modifications Impact on Administration Persistence in Patients With Metastatic Breast Cancer (Mbc)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Eribulin in Pretreated Metastatic Breast Cancer Patients: Results of the TROTTER Trial—a Multicenter Retrospective Study of Eribulin in Real Life
SpringerPlus
Multidisciplinary
Use of Eribulin as an Earlier-Line Chemotherapy for Patients With HER2-negative Metastatic Breast Cancer
Journal of Cancer
Oncology
Outcome of Eribulin as a Late Treatment Line for Thai Metastatic Breast Cancer Patients
OncoTargets and Therapy
Oncology
Pharmacology
Oral Fluoropyrimidines Among the New Drugs for Patients With Metastatic Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Management of Patients With Metastatic Renal Cell Cancer and Bone Metastases
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Disease-Free Survival in Patients With Non-Metastatic Breast Cancer
Revista da Associacao Medica Brasileira
Medicine